DOVA - Dova Pharmaceuticals' (DOVA) CEO David Zaccardelli on Q4 2018 Results - Earnings Call Transcript
Dova Pharmaceuticals, Inc. (DOVA)
Q4 2018 Earnings Conference Call
March 5, 2019 9:00 AM ET
Company Participants
David Zaccardelli – President and Chief Executive Officer
Mark Hahn – Chief Financial Officer
Kevin Laliberte – Vice President-Product Development
Jason Hoitt – Chief Commercial Officer.
Conference Call Participants
Eun Yang – Jefferies
Jonathan Miller – Evercore
Matt Bannon – JPMorgan
Brad Canino – SVB Leerink
Matt Kaplan – Ladenburg Thalmann
Joe Pantginis – H.C. Wainwright
Presentation
Operator
Good morning, and welcome to Dova Pharmaceuticals Fourth Quarter and Full Year 2018 Financial Results and Operating Highlights Conference Call.